Jci_page_head_homepage_01 Jci_page_head_homepage_02
Jörg Reutershan, Margaret A. Morris, Tracy L. Burcin, David F. Smith, Daniel Chang, Mary S. Saprito, Klaus Ley
Published in Volume 116, Issue 3
J Clin Invest. 2006; 116(3):695–702 doi:10.1172/JCI27009
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 7
CXCR2 expression in lung homogenate.

(B) Leukocytes (CD45+) and nonleukocytes (CD45) were analyzed separately for their expression of CXCR2 (shown in C and A, respectively). (A) Among all CD45cells, endothelial cells were identified by their expression of CD31. The majority of endothelial cells (~67%) expressed CXCR2. In addition, CXCR2 was found in a large population of CD31 cells. (C) Among all leukocytes (CD45+), only PMNs (GR-1high) exhibited CXCR2 surface expression. Neither monocytes/macrophages (Mfs; GR-1intermediate) nor most lymphocytes (Lys; GR-1negative) showed detectable CXCR2 expression.